Search
for
Sort by
Research 61–90 of 67
- Diseases of the Canine Prostate Gland
- ES01.01 Chemotherapy is Strictly Additive to Immunotherapy
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy
- Nanotechnology-Driven Delivery of Caffeine Using Ultradeformable Liposomes-Coated Hollow Mesoporous Silica Nanoparticles for Enhanced Follicular Delivery and Treatment of Androgenetic Alopecia
- Prostatakarzinom
- ZALCITABINE
- Mitoxantrone
- Mitoxantrone
- Mitoxantrone, Etoposide and Prednisolone—a Novel Combination in The Treatment of Relapsed and Refractory Lymphoma
- [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer].
- Doxetaxel: new indication. Prostate cancer: a few more weeks.
- Cytostatics and immunosuppressive drugs
- Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Hypertensive crisis associated with St. John’s Wort
- Clinical Development of Topoisomerase-Interactive Drugs
- Efluvio anágeno. Hallazgos tricoscópicos
- Supplements That May Counteract Side Effects from Conventional Cancer Therapies
- Use of chemotherapy during human pregnancy
- Mucocutaneous reactions to chemotherapy
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Drug Reactions Affecting Hair: Diagnosis
- Drug-Induced Hair Disorders
- Redefining hormone resistance in prostate cancer
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Alopecia in Association with Malignancy: A Review
- An Update on Drug-Induced Pigmentation